| Year | Sales (US Dollars Per Capita) | Year-on-Year Variation (%) |
|---|---|---|
| 2024 | 7.8 | |
| 2025 | 7.7 | -1.28% |
| 2026 | 7.6 | -1.30% |
| 2027 | 7.6 | 0.00% |
| 2028 | 7.5 | -1.32% |
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is approximately -0.96%. This indicates a slight declining trend over the 5-year period.
Future Trends to Watch
As antibacterial medicine sales in Finland are projected to decline slightly, watch for efforts to develop new antibiotics, increased emphasis on antibiotic stewardship programs, and the impact of public health campaigns aimed at reducing unnecessary antibiotic use. Additionally, monitor the influence of evolving healthcare policies and any breakthroughs in alternative treatments or preventive measures.
